Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 24, 2011 07:01 ET | Source: Aeolus Pharmaceuticals

Aeolus Pharmaceuticals Announces NIH Counteract Grant Award to Develop AEOL 10150 as a Treatment Against Nerve Agent Exposure

MISSION VIEJO, CA--(Marketwire - Oct 24, 2011) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company leveraging significant funding from the U.S. Department of...
October 10, 2011 11:55 ET | Source: Aeolus Pharmaceuticals

Aeolus Pharmaceuticals Announces $12.7 Million NIH Counteract Grant Award to Continue Development of AEOL 10150 as a Treatment Against Chlorine and Sulfur Mustard Gas Exposure

MISSION VIEJO, CA--(Marketwire - Oct 10, 2011) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company that is leveraging up to $140M of government funding in...
October 05, 2011 11:28 ET | Source: Aeolus Pharmaceuticals

Roth Capital Initiates Equity Research Analyst Coverage on Aeolus

MISSION VIEJO, CA--(Marketwire - Oct 5, 2011) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company that is leveraging up to $140M of government funding in...
September 23, 2011 13:22 ET | Source: Aeolus Pharmaceuticals

Aeolus Pharmaceuticals Files Request for Orphan Drug Designation of AEOL 10150 for Mitigation, and/or Treatment of Delayed Effects of Acute Radiation Exposure of the Lung

MISSION VIEJO, CA--(Marketwire - Sep 23, 2011) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company that is leveraging up to $140M of government funding in...
September 06, 2011 17:41 ET | Source: Aeolus

Aeolus to Present at Stifel Nicolaus' Annual Healthcare Conference

MISSION VIEJO, CA--(Marketwire - Sep 6, 2011) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company that is leveraging up to $140M of government funding in...
September 01, 2011 11:16 ET | Source: Aeolus Pharmaceuticals

Aeolus Pharmaceuticals' Announces Presentation of AEOL10150 Data at the 14th International Congress of Radiation Research

MISSION VIEJO, CA--(Marketwire - Sep 1, 2011) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company that is leveraging up to $140M of government funding in...
August 29, 2011 14:33 ET | Source: Aeolus Pharmaceuticals

Ladenburg Thalmann Initiates Equity Research Analyst Coverage on Aeolus

MISSION VIEJO, CA--(Marketwire - Aug 29, 2011) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS) today announced that Ladenburg Thalmann & Co. Inc. initiated equity research...
August 15, 2011 16:56 ET | Source: Aeolus Pharmaceuticals

Aeolus Pharmaceuticals Announces Third Quarter Fiscal Year 2011 Results

MISSION VIEJO, CA--(Marketwire - Aug 15, 2011) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) announced today financial results for the three months ended June 30, 2011. The Company reported net...
May 26, 2011 19:32 ET | Source: Aeolus Pharmaceuticals

Noble Financial Initiates Equity Research Analyst Coverage on Aeolus

MISSION VIEJO, CA--(Marketwire - May 26, 2011) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) today announced that Noble Financial Group initiated equity research coverage on the Company with a "Buy"...

keyboard_arrow_left Previous Page